The Vendorification of Medicare Advantage
{"Abstract":[0],"Medicare":[1],"Advantage":[2],"(MA)":[3],"plans":[4],"increasingly":[5],"outsource":[6],"core":[7],"functions":[8],"to":[9,75,84],"third-party":[10],"vendors,":[11],"a":[12],"trend":[13],"termed":[14],"the":[15,101],"\\"vendorification\\"":[16],"of":[17,94],"MA.":[18],"Vendors":[19],"now":[20],"play":[21],"major":[22],"roles":[23],"in":[24],"star-rating":[25],"maximization,":[26],"risk-code":[27],"capture,":[28],"and":[29,42,71,81],"prior":[30,36],"authorization,":[31],"with":[32],"evidence":[33],"that":[34,58,104],"vendor-conducted":[35],"authorization":[37],"yields":[38],"higher":[39],"denial":[40],"rates":[41],"more":[43,98],"appeal":[44],"reversals":[45],"than":[46],"reviews":[47],"conducted":[48],"internally":[49],"by":[50,62],"insurers.":[51],"This":[52],"commentary":[53],"examines":[54],"three":[55],"potential":[56],"challenges":[57],"may":[59],"be":[60],"posed":[61],"vendorification:":[63],"increased":[64],"federal":[65],"spending":[66,96],"through":[67],"non-budget-neutral":[68],"risk":[69],"adjustment":[70],"quality":[72],"bonuses,":[73],"opportunities":[74],"game":[76],"medical":[77],"loss":[78],"ratio":[79],"requirements,":[80],"weakened":[82],"accountability":[83],"beneficiaries’":[85],"long-term":[86],"health.":[87],"Potential":[88],"policy":[89],"responses":[90],"include":[91],"mandatory":[92],"reporting":[93],"vendor":[95,107],"and,":[97],"fundamentally,":[99],"reforming":[100],"payment":[102],"incentives":[103],"make":[105],"revenue-generating":[106],"services":[108],"profitable.":[109]}
Authors
- David J. Meyers (ORCID: https://orcid.org/0000-0002-4081-1751)
- Jeffrey Marr (ORCID: https://orcid.org/0000-0002-3733-0244)
Institutions
- Brown University (US)
Publication Details
- Journal
- Health Affairs Scholar
- Published
- 2026-09-04
- DOI
- https://doi.org/10.1093/haschl/qxag243
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00